rivastigmine has been researched along with caffeic acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Chen, Q; Chen, Z; Chu, J; Digiacomo, M; Gu, Q; Han, Y; Macchia, M; Nesi, G; Pi, R; Rapposelli, S; Sestito, S; Tu, Y; Wang, S; Yang, X | 1 |
| Andrisano, V; Apperley, KYP; Bartolini, M; Baschieri, A; Basso, M; Chen, HH; De Simone, A; Guardigni, M; Keillor, JW; Kobrlova, T; Milelli, A; Montanari, S; Soukup, O; Valgimigli, L | 1 |
| Khan, KA; Krishnadas, N; Kumar, N; Mudgal, J; Nampoothiri, M; Nayak, PG; Rao, CM; Shenoy, RR | 1 |
3 other study(ies) available for rivastigmine and caffeic acid
| Article | Year |
|---|---|
Discovery of novel rivastigmine-hydroxycinnamic acid hybrids as multi-targeted agents for Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Cholinesterase Inhibitors; Coumaric Acids; Drug Discovery; Humans; In Vitro Techniques; Neuroprotective Agents; Rivastigmine; Structure-Activity Relationship | 2017 |
Hydroxy-substituted trans-cinnamoyl derivatives as multifunctional tools in the context of Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Cinnamates; Dose-Response Relationship, Drug; Free Radical Scavengers; Glycogen Synthase Kinase 3 beta; Molecular Structure; Stereoisomerism; Structure-Activity Relationship | 2017 |
Impact of caffeic acid on aluminium chloride-induced dementia in rats.
Topics: Aluminum Chloride; Aluminum Compounds; Animals; Caffeic Acids; Chlorides; Cholinesterase Inhibitors; Dementia; Male; Nitrites; Phenylcarbamates; Rats; Rats, Wistar; Rivastigmine | 2013 |